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Boston, Massachusetts
Surgical therapy with mapping-guided subendocardial
resection was used in 30 patients with drug-refractory
ventricular tachycardia. Results of preoperative, intraop-
erative and postoperative electrophysiologic evaluation
and long-term clinical follow-up are reported . Left
ventricular aneurysm was located in the inferior wall
in 8 patients and in the anterior wall in 22. Left ven-
tricular mapping was performed in 15 patients preoper-
atively and in all 30 patients intraoperatively . Sub-
endocardial resection was supplemented with cryoabla-
tion in 26 patients and with laser photocoagulation in 4 .
Coronary bypass surgery was performed in 27 patients .
The surgical mortality rate was 10% ; the three deaths
were due to cardiogenic shock, pneumonia and sepsis,
respectively .
At postoperative electrophysiologic study, ventricular
tachycardia was inducible in 8 (30%) of 27 patients .
Previously ineffective antiarrhythmic drugs were effective
in preventing the induction of ventricular tachycardia in
With the recognition of the limitations of pharmacologic,
catheter ablation and implantable device therapy for sus-
tained ventricular tachycardia, electrophysiologically di-
rected surgery has assumed an increasing role in the man-
agement of patients with this condition (1-1 ) . Since the
initial description of a nondirected aneurysmectomy for
ventricular tachycardia (20), the techniques of mapping-
guided identification of the site of tachycardia origin have
evolved and surgical approaches have been refined (4,5) .
Excision of scarred subendocardium, as initially described
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four of these eight patients . Two of the remaining four
patients received an automatic implantable cardioverter-
defibrillator ; the other two were treated with amiodarone .
At a mean follow-up period of 18 ± 17 months (range I to
52), there has been one sudden death and one nonfatal
recurrence of ventricular tachycardia in the 18 patients
without inducible arrhythmias postoperatively . Among the
eight patients with inducible ventricular tachycardia after
subendocardial resection, there has been one nonfatal ven-
tricular tachycardia recurrence .
Thus, among the 27 patients surviving surgery, 17
(63%) were cured with surgery alone, and another 7 (26%)
had their ventricular tachycardia controlled with drugs
(n = 5) or the defibrillator (n = 2) . Inability to completely
map the tachycardia, a clinical history of cardiac arrest
requiring resuscitation and the presence of myocardial
infarction within 2 months predicted postoperative ar-
rhythmia inducibility and recurrence .
(J Am Coll Cardiol 1 8 ;14 1  -208)
1  
by Josephson et al . (5), is the most widely used technique for
removal of tissue involved in the origin of the tachycardia
(21) . Postoperative arrhythmia induction by programmed
stimulation and recurrence of clinical tachycardia is pre-
vented in most patients with this approach (7,8,10,13) . In
this study, we report the results of mapping-guided suben-
docardial resection supplemented by laser or cryosurgery in
30 patients with drug-refractory ventricular tachycardia .
Clinical outcome is analyzed by life table methodology, and
the influence of clinical, hemodynamic and electrophysio-
logic factors on postoperative arrhythmia inducibility and
long-term arrhythmia control is analyzed by stepwise logistic
regression analysis .
Methods
Study patients . The study group includes the first 30
consecutive patients with prior myocardial infarction who
underwent subendocardial resection for control of sustained
0735-10 7/8 /$3 .50
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ventricular tachycardia at our center between 1 84 and 1 88 .
Patients were selected on the basis of the presence of an
angiographically defined discrete akinetic or dyskinetic seg-
ment of the left ventricle appropriate for surgical resection .
For inclusion in this study patients had ventricular tachycar-
dia resistant to antiarrhythmic drug therapy as the primary
indication for surgery . Finally, all patients had subendocar-
dial resection directed by preoperative or intraoperative
mapping, or both .
Electrophysiologic study . The baseline study was per-
formed with patients in the fasting, nonsedated state . All
antiarrhythmic drugs were discontinued for at least five drug
half-lives . Three quadripolar 6F electrode catheters were
introduced through the femoral vein under local anesthesia
with use of the Seldinger technique . Under fluoroscopic
guidance, the catheters were placed in the high lateral right
atrium and across the tricuspid valve for recording from the
bundle of His and right ventricular apex . Intracardiac re-
cordings were filtered between 30 and 500 Hz and were
displayed simultaneously with three surface electrocardio-
graphic (ECG) leads on a multichannel oscilloscope (Hon-
eywell, Electronics for Medicine VR-12) . All data were
stored on a magnetic tape for subsequent analysis, and were
retrieved on photographic paper at speeds of 100 to 200
mm/s. Programmed cardiac stimulation was carried out with
a constant current stimulator (model 5328, Medtronic), with
rectangular pulses 2 ms in duration at two times diastolic
threshold .
The stimulation protocol (22) consisted of single and
double extrastimuli during sinus rhythm, and three basic
drive cycle lengths followed by triple extrastimuli during
sinus rhythm and ventricular pacing at the right ventricular
apex and outflow tract . Left ventricular stimulation was
performed only if no arrhythmia was induced by stimulation
at the two right ventricular sites at the baseline study .
Sustained ventricular tachycardia was defined as tachycar-
dia lasting >30 s or requiring termination because of hemo-
dynamic compromise .
After the baseline study, serial electropharmacologic test-
ing was undertaken in an attempt to find effective antiar-
rhythmic treatment. A drug was considered to be effective if
at the follow-up study fewer than six beats of ventricular
tachycardia could be induced with the stimulation protocol
just described .
Preoperative evaluation and electrophysiologic mapping .
All patients underwent right and left heart catheterization,
coronary angiography and biplane ventriculography . Pre-
operative mapping was carried out in the electrophysiology
laboratory with use of Josephson quadripolar electrode
catheters (USCI Corporation, Billerca, Massachusetts) in-
troduced through the femoral or brachial arteries and moved
to multiple endocardial sites, including one apical, three
septal, four anterior wall and four posterior wall sites, under
fluoroscopic guidance (23) . Hemodynamic instability during
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the induced tachycardia, unstable angina and >75% stenosis
of the left main coronary artery were contraindications to
mapping in the electrophysiology laboratory . Induction of
ventricular tachycardia was accomplished by means of a
right ventricular electrode catheter with the previously de-
scribed programmed stimulation protocol . The earliest site
of activation in the last half of diastole during ventricular
tachycardia was defined as the site of origin of the arrhyth-
mia. Left ventricular mapping was considered incomplete if
one apical, two septal, two anterior wall and two posterior
wall sites could not be recorded . The ventricular tachycardia
configuration was considered distinct if the bundle branch
configuration differed or if the frontal plane QRS axis was
> 0° divergent .
Intraoperative mapping and surgical techniques . Intraop-
erative mapping was performed under general anesthesia
and normothermic cardiopulmonary bypass . A right ventric-
ular endocardial electrode catheter was used for arrhythmia
induction, and two epicardial electrodes placed on the right
ventricular outflow tract were used to record reference
electrograms . At least three surface ECG leads (I, aVF and
modified V,) were used to compare intraoperatively induced
ventricular tachycardia configurations with the preoperative
arrhythmias. Ventricular tachycardias were considered of
the same configuration if the bundle branch configuration
and the QRS axis were similar. Local electrograms were
recorded by means of a tripolar ring electrode or a malleable
electrode probe, each with 2 mm interelectrode distance,
moved in a clockwise fashion around the margin of the
myocardial scar in concentric circles that were progressively
deeper by 1 cm relative to the ventriculotomy (12) . Endocar-
dial mapping was considered incomplete if < 12 sites on the
circumference of the ventriculotomy were recorded for each
ventricular tachycardia configuration .
Epicardial mapping during sinus rhythm and during
ventricular tachycardia was not performed in 1  patients
because it was believed that the additional information
gained did not justify the prolongation of cardiopulmonary
bypass . In all patients, a ventriculotomy was made at the
center of the aneurysm . Endocardial mapping was then
performed and the endocardial site of ventricular tachycar-
dia origin was sought for each tachycardia configuration .
The surgical technique subsequently applied included resec-
tion of as much transmural scar from the aneurysm as
possible . A 2 mm deep subendocardial resection also was
performed at the site of earliest diastolic activity, with a I to
2 cm margin on all sides . In patients with a septal or papillary
muscle origin of the tachycardia, carbon dioxide laser or
cryothermia was used as a supplement around the margins of
the resected tissue . Our technique of laser photocoagulation
has been previously described (24) . In all other patients,
cryothermal lesions were created around the margins of the
subendocardial resection by freezing at -60°C for 2 min with
a 15 mm cryoprobe .
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After the completion of subendocardial resection, pro-
grammed stimulation was repeated. If ventricular tachy-
cardia was still inducible, mapping and subendocardial
resection were repeated (25) . When mapping-guided suben-
docardial resection was complete and ventricular tachycar-
dia was no longer inducible, the ventriculotomy site was
closed . The aorta was then cross-clamped and additional
surgical procedures were performed. These included coro-
nary artery bypass grafting in 27 patients, mitral valve
replacement in 2 patients, aortic valve replacement in I
patient and both mitral valve replacement and closure of a
ventricular septal defect in 1 patient . In those patients who
were considered at risk for postoperative ventricular tachy-
cardia recurrence as a result of incomplete mapping, multi-
ple configurations of ventricular tachycardia or inferoposte-
rior wall aneurysm, prophylactic patches for the automatic
implantable defibrillator were implanted .
Postoperative evaluation . All the patients were continu-
ously monitored during the postoperative period . At 7 to 10
days postoperatively, the electrophysiologic study was re-
peated. In those patients with inducible ventricular tachy-
cardia at the postoperative study, serial drug testing was
performed. If antiarrhythmic agents were not successful in
preventing arrhythmia induction, an automatic implantable
cardioverter-defibrillator (AICD) was implanted or amio-
darone therapy was used .
Clinical follow-up . After hospital discharge, patients were
followed up by their referring cardiologist and at our arrhyth-
mia clinic every 3 months in the first year and every 6 months
thereafter. Any symptoms of arrhythmia recurrence were
noted and evaluated with Holter ECG monitoring .
Statistical analysis . All continuous variables are reported
as mean values ± SD . Fisher's exact test was used to
determine statistical significance (p < 0 .05) of single varia-
bles. The variables that were analyzed included age ( or
<65 years), gender, number of antiarrhythmic drug trials,
prior use of amiodarone, ejection fraction (>_ or <30%),
clinical history of cardiac arrest requiring both cardiopulmo-
nary resuscitation and cardioversion or defibrillation, recent
(within 2 months) myocardial infarction, number of ventric-
ular tachycardia morphologies, cycle length of ventricular
tachycardia (> or <300 ms), type of bundle branch config-
uration, location of aneurysm and incomplete mapping . All
variables were initially analyzed separately to identify those
that had a predictive value for postoperative arrhythmia
inducibility, sudden death or nonfatal ventricular tachycar-
dia recurrence . Predictors of tachycardia inducibility or
recurrence were further identified by stepwise logistic re-
gression analysis and the two x two contingency tables (26) .
Actuarial curves for survival and recurrent ventricular
tachycardia were constructed using standard life table tech-
niques (27) .
2 0 1
Results
Patient characteristics (Table 1) . The initial 30 consecu-
tive patients undergoing mapping-guided subendocardial re-
section at our institution are included in the present study .
There were 23 men and 7 women, aged 64 ± 7 years (range
53 to 78) . Coronary artery disease was present in all patients .
Left ventricular ejection fraction averaged 32% ± 11%
(range 15% to 58%) . The presenting clinical arrhythmia was
sustained ventricular tachycardia with hemodynamic com-
promise in 26 patients and ventricular fibrillation in 4 pa-
tients . In three patients, preoperative electrophysiologic
evaluation was precluded by critical coronary lesions (left
main or left main equivalent) and unstable angina . Primary
electrophvsiologic study was performed in the remaining 27
patients in the drug-free state . Sustained monomorphic
ventricular tachycardia (mean cycle length 313 ± 5  ms) was
inducible in 26 of the 27 patients . The arrhythmia was
induced with programmed ventricular stimulation at the right
ventricular apex in 22 patients, right atrial stimulation in 2
patients, right ventricular outflow tract stimulation in I
patient and left ventricular stimulation in I patient . Ventric-
ular fibrillation was induced with double extrastimuli during
sinus rhythm at the right ventricular apex in one patient .
Serial electropharmacologic testing was performed in the 27
patients with inducible arrhythmia . Patients underwent a
mean of 4.0 ± 1 .2 (2 to 6 per patient) unsuccessful antiar-
rhythmic drug trials before mapping-guided subendocardial
resection (Table I) .
Preoperative catheterization and electrophysiologic map-
ping . Cardiac catheterization, coronary angiography and
left ventriculography revealed left main coronary artery
disease in 3 patients . one-vessel disease in 5 . two-vessel
disease in 4 and three vessel disease in 21 ; the left ventricular
dyskinetic or akinetic segment was located anteriorly in 22
patients and inferiorly in 8 patients (Table 1) . Preoperative
electrophysiologic mapping during ventricular tachycardia
was attempted in 15 patients (Table 2) . It was incomplete in
three patients because of hemodynamic instability necessi-
tating interruption of the tachycardia within 30 s of induc-
tion. In these three patients, mapping was done during sinus
rhythm .
Intraoperative mapping (Table 2). Intraoperative map-
ping was considered complete for all ventricular tachycardia
configurations in 1  of 30 patients . In the I I patients with no
inducible sustained ventricular tachycardia intraoperatively,
complete mapping was precluded by nonsustained ventricu-
lar tachycardia in five patients, repetitive induction of ven-
tricular fibrillation in four and no inducible arrhythmia in
two. In two patients, each having five ventricular tachycar-
dia configurations, incomplete mapping was performed for
one and two configurations, respectively, with the remaining
ventricular tachycardia configurations being mapped com-
pletely . In two patients with inadequate Intraoperative map-
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Table 1 .
Clinical, Angiographic and Electrophysiologic Characteristics of 30 Patients Undergoing
Mapping-Guided Subendocardial Resection
ping, the data from the preoperative (complete) mapping
were used to guide subendocardial resection . Overall, 52
distinct ventricular tachycardia configurations (1 to 5 per
patient) with a mean cycle length of 367 ± 100 ms were
mapped in 25 patients . A right bundle branch block pattern
was present in 32 and a left bundle branch block pattern in 20
tachycardias . Epicardial and endocardial mapping was per-
formed in the initial 11 patients, whereas in the subsequent
patients, only endocardial mapping was performed . The
results of preoperative and intraoperative mapping were
concordant, with the same ventricular tachycardia config-
uration induced at both mappings, except in one patient who
had three of five ventricular tachycardia configurations in-
duced and mapped only intraoperatively . In another two
A = anterior  CL = cycle length (ms)   EPS = electrophysiologic study ; F = female ; I = inferior   LM = left main
coronary artery disease   LVEF = left ventricular ejection fraction   M = male   Ml = myocardial infarction ; IVD,
2VD, 3VD = one, two and three vessel disease, respectively   VA = ventricular arrhythmia ; VF = ventricular
fibrillation   VT = ventricular tachycardia . + = present .
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patients with inadequate intraoperative ventricular tachycar-
dia mapping, the data from sinus rhythm mapping were used
to guide subendocardial resection .
Surgery . After subendocardial resection, attempts at re-
induction of ventricular tachycardia were made in the final
22 patients . If the mapped or an alternative ventricular
tachycardia was still inducible, mapping was performed
again, followed by further subendocardial resection until
ventricular tachycardia could not be induced (25) . Suben-
docardial resection in patients with successful mapping was
thus selectively localized and did not include all visible
scars. However, when mapping was incomplete (11 patients)
a visually guided extended subendocardial resection was
performed and supplemented by cryothermia or laser pho-
Patient
No .
Age/(yr)
&
Gender
Clinical
Arrhythmia
Coronary
Anatomy Aneurysm
LVEF
(%)
EPS
VA/CL
No .
of
Drugs
Tried
MI <2
Mo
I 60M
VF 3 VD A 35 VT/250 4
2 70M VT 3 VD 1 25 VT/250 5
3 60M VF I VD A 25
VT/350 5 + (A)
4
66F VT 3 VD, LM A 20 VT/2 0 5 + (A)
5 60M VT 3 VD 1 25 VT/330 6
6 67F VT 3 VD A
25 VT/3 0 4
7
5 F VT 3 VD A 3  VT/250 5 + (A)
8 53M VT 3 VD A 45 VT/300 3
  64M
VT 3 VD A 30 VT/400 6 + (A)
10
64F VT 3 VD A 27 VT/300 5 + (A)
11 70M VT 3 VD A 25 VT/330 4
12 64M VF
3 VD
1
44 VT/270 5
13 60M VT I VD A 40 VT/280 3
14 74M VT 3 VD, LM 1 50 VT/300
5
15 53M VT
I VD, LM A 23 - 2
16 54M VF 3 VD A 15 VT/400 3
17 63F VT I VD 1 40 VT/370 5
18 67M VT 3 VD A 58 VT/280 4
1  60M VT 3 VD 1 35 VT/250 5
20 65M VT
2 VD A 30 - 2
21 70M VT 3 VD A 20 - 4 + (A)
22 57M VT
I VD
A
37 VT/255 5
23 58F VT 2 VD A 16 VT/360 3 + (A)
24 58M VT 3 VD 1 37 VT/400 2 + (I)
25 72M VT 3 VD A 30 VF 2
26 70M VT 3 VD A 47 VT/270 2
27 78M VT 3 VD A 25 VT/420 3
28 70M VT
2 VD
1
27 VT/270
3
2  6 M VT 3 VD A 17 VT/210 4
30 73F VT 2 VD A 33 VT/350 5
Mean 64 32 313 4 .0
±SD 7 11 5  1 .2
tocoagulation . In addition to subendocardial resection, cor-
onary artery bypass grafting was performed in 27 patients .
One patient had closure of a postmyocardial infarction
ventricular septal defect and mitral valve replacement . An-
other patient had aortic valve replacement for critical aortic
stenosis before he died postoperatively of sepsis . Suben-
docardial resection was extended into the papillary muscles
and the mitral valve apparatus, necessitating mitral valve
replacement in two patients with submitral ventricular
tachycardia origin. Subendocardial resection was comple-
mented by cryothermia in 26 patients and laser photocoag-
ulation in 4 . Eighteen patients received prophylactic elec-
trodes for the automatic implantable cardioverter-
defibrillator.
Surgical results . Among the 30 patients, the surgical
mortality rate was 10% ; all three deaths occurred postoper-
atively (3 days to 4 weeks) and were due to cardiogenic
530 (Inc), 400 (Inc)
*Incomplete mapping ; trefused electrophysiologic study
; $ventricular tachycardia morphology different from clinical (preoperative) arrhythmia  
§preoperative mapping data . Endo = endocardial   Epi = epicardial ; Inc = incomplete (mapping)
  Intraop = intraoperative   LB = left bundle (branch block)
 
NI = noninducible
  NS = nonsustained   PD = postoperative death
  Postop = postoperative   Preop = preoperative   RB = right bundle (branch block)
; Rec =
recurrence of ventricular tachycardia   SD = sudden death   SR = sinus rhythm mapping   - = absent   other abbreviations as in Table I
.
shock, pneumonia and sepsis, respectively . The postopera-
tive course was transiently complicated by pneumonia in 3
patients, atria) flutter/fibrillation in 12 patients and complete
atrioventricular block in 5 patients. Another three patients
required hemodynamic support by intraaortic balloon pump-
ing while coming off cardiopulmonary bypass . Perioperative
myocardial infarction without complications occurred in one
patient .
Postoperative electrophysiologic study . Twenty-six of the
27 surgical survivors underwent study 7 to 10 days postop-
eratively ; I patient refused repeat evaluation . Ventricular
tachycardia was inducible in eight patients (30%) . Among
these eight patients, four subsequently had their arrhythmia
controlled by antiarrhythmic drugs that were ineffective
preoperatively . Two of the remaining four patients received
an automatic implantable cardioverter-defibrillator (AIM,
and two received amiodarone (Fig . I). Among the eight
JACC Vol . 14,
July 1 8   1  -208
Table 2 . Results
No . I
of Electrophysiologic Mapping and Surgery
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in 30 Patients
Patient Preop
Intraop Mapping Ventricular Tachycardia
Postop
No . Mapping Epi Endo No . Configurations CL EPS Rec SD
l Inc* 0 VF
2 + + 1 LB 250 N I
3 + + 2 RB, RB 300, 350
+ t
4
+
I RB
2 0 PD
5 + + 2 LB, RB 500, 375 NI
6
+
3 RB, LB . LB 3 0 . 440,4 0 NI
7 + + + 2 LB, RB 250, 350 NI
8 Inc + (SR)* 0 NI NI
  + (SR) + (SR)* 0 VF
10
-
+ + I LB 250
+
II + + 2 LB, RB 380, 580 PD
12 Inc Inc
+ 2
LB, RB 260, 350 NI
+
13 + + I RB 280
14 Inc 1* 1 RB (NS) 4000)
+
15 -
+
I RB 300 N I
16 + + + I RB 400
+$
+
17
+
Inc (NI) 2 RB, LB§ 400, 330 NI
18 + + + 2 LB, RB 330, 400 NI
1  + + + 3 LB, RB . RB 500, 520 . 540 NI
20
+
3 RB. RB, RB 250 . 260, 270 PD
21 Inc* 1 LB (NS), VF 1 0 (Inc) +
22
+
2 LB, RB 255, 2 5 NI
23
+
Inc (NS) 2 RB, LB§ 360, 440 N I
24 +* 5 RB, LB . RB, RB, RB
250, 300
. 330, 400, 550 (Inc) +$
25 Inc* 0 VF NI
26
Inc* 0
VF
NI
27 Inc + 2 RBA B 220, 350 NI
28 - + 4 RB, RB, LB . LB 2 0, 320, 450 . 3 0 NI
2 
+ +
1 LB 310 NI
30
+
+*
5
LB, RB, RB, RB . RB 560 . 500 . 420 N I
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I
8 inducible VT
drug testing
0 VT recurrences
patients with inducible tachycardia, five had incomplete or
no mapping, two had an inferoposterior aneurysm and one
had multiple (n = 5) ventricular tachycardia morphologies
(Tables I and 2) . The incidence of postoperative ventricular
tachycardia induction was significantly higher in patients
with a recent (within 2 months) myocardial infarction (71%
[5 of 7]) compared with the patients who had a remote
infarction (15% [3 of 20]) (p = 0 .011) .
Clinical follow-up . During a long-term follow-up period
of 18 ± 17 months (range I to 52), three deaths occurred
among the 27 survivors (two due to congestive heart failure
and one sudden death) . Nonfatal recurrence of ventricular
tachycardia was noted in two patients (Fig . 1). Life table
analysis (Fig . 2) demonstrated that at 51 months, the actu-
arial probability of freedom from sudden cardiac death was
0.88, from nonsudden cardiac death 0 .78 and from nonfatal
ventricular tachycardia recurrence 0 .62 . Among the eight
patients who had inducible ventricular tachycardia postop-
eratively, two died of heart failure at 6 and 7 months after
discharge, respectively . Both patients had required mitral
valve replacement, one during subendocardial resection and
the other 4 months postoperatively . One of the remaining six
patients had nonfatal ventricular tachycardia recurrence 45
months after surgery . Among the other 18 patients whose
arrhythmia was not inducible, one sudden death occurred in
a patient who had class III congestive heart failure with
progressive mitral regurgitation due to prosthetic mitral
valve dehiscence and was not considered a candidate for
reoperation . In addition, there was one nonfatal ventricular
tachycardia recurrence, requiring AICD implantation in a
patient who had incomplete mapping (Patient 8, Table 2) .
30 patients
27 operative survivors
26 postoperative EPS*
	 I	
I
18 no Inducible VT
4 inducible VT 4 no inducibie VT
I I 1
2 AICD 2 Amio 1 VT recurrencet
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Figure 1. Flow chart showing the re-
sults of mapping-guided subendocardial
resection in 30 patients with drug-
refractory ventricular tachycardia (VT) .
*One patient refused follow-up electro-
physiologic study (EPS) and has had no
recurrence of ventricular tachycardia ;
**this patient received an automatic
implantable cardioverter-defibrillator
(AICD); tthis patient received a heart
1 So
transplant because of progressive heart
failure . Amio = amiodarone ; SD = sud-
den death .
1 VT recurrence**
Finally, 17 (63%) of the 27 patients were cured with surgery
alone, whereas another 5 patients remained free of ventric-
ular tachycardia recurrence on treatment with antiarrhyth-
mic drugs . Two patients requiring implantation of the AICD
for persistently inducible arrhythmia have also remained free
of arrhythmia recurrence or defibrillator discharge . Thus,
Figure 2. Cumulative survival without recurrent ventricular tachy-
cardia (VT), nonsudden cardiac death or sudden death in the 27
operative survivors,
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overall, 24 (8 %) of the 27 survivors have had their ventric-
ular tachycardia controlled .
Predictors of surgical failure . Univariate analysis of var-
ious clinical, hemodynamic, angiographic and electrophysi-
ologic variables identified three predictors of postoperative
ventricular tachycardia inducibility or clinical (fatal and
nonfatal) arrhythmia recurrence, or both . These predictors
are 1) a history of cardiac arrest requiring cardiopulmonary
resuscitation and cardioversion, with all five patients with
such history failing surgery (p = 0 .003) ; 2) a history of recent
(within 2 months) myocardial infarction, with 5 (71%) of 7
patients with recent infarction having inducible ventricular
tachycardia postoperatively (versus 3 [15%] of 20 patients
without recent infarction ; p = 0.011) ; and 3) incomplete
mapping, with 6 (67%) of   patients with incomplete mapping
failing surgery (versus 4 [22%] of 18 patients with complete
mapping ; p = 0.03 ) . Multivariate analysis by stepwise
logistic regression was further undertaken to identify inde-
pendent predictors of surgical failure . The analysis showed
that incomplete mapping (p = 0.040) and recent myocardial
infarction (p = 0.04 ) were independently associated with
surgical failure . Analysis of factors influencing operative
mortality (three deaths [10%]) did not clearly identify any
factors that predicted perioperative mortality . However, this
analysis suggested an association between age (?65 years)
and surgical death, with all three deaths occurring in patients
aged >_65 years .
Discussion
Previous investigations . Multiple reports (1-3,28-31) have
defined a large group of patients at risk for sudden cardiac
death, including those with prior out-of-hospital cardiac
arrest and sustained ventricular tachycardia . With an appre-
ciation of the long-term limitations of pharmacologic therapy
for prevention of ventricular tachycardia recurrence (3,2 -
33), a number of nonpharmacologic approaches, including
catheter ablation (16,17,34-36), electrical devices (14,15,18,
1 ,37) and several surgical approaches (3-13,20,23-
25,38-61) have evolved . In this study, surgical therapy with
mapping-guided subendocardial resection in 30 patients,
selected on the basis of drug-refractory sustained ventricular
tachycardia or ventricular fibrillation and a prior myocardial
infarction with a discrete akinetic or dyskinetic area of the
left ventricle, resulted in a postoperative inducibility rate of
30% and an operative mortality rate of 10%. The 10%
surgical mortality rate in this study is comparable with the
rate of  % reported by Miller et al . (8) and that of 17%
reported by Garan et al . (48) . Also, the 30% incidence of
sustained ventricular tachycardia induced postoperatively is
comparable with the 28% incidence reported by Miller et al .
(8) and the 34% reported by Garan et al . (48) .
Furthermore, factors that predicted postoperative ar-
rhythmia induction or spontaneous ventricular tachycardia
MANOLIS ET AL .
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recurrence were identified in this series . Among multiple
clinical, hemodynamic and electrophysiologic variables an-
alyzed, the presence of a myocardial infarction within 2
months, inability to map the tachycardia completely and a
clinical history of cardiac arrest requiring resuscitation pre-
dicted postoperative ventricular tachycardia inducibility and
recurrence . In addition, previous reports (8,48) have found
other factors, including disparate sites of ventricular tachy-
cardia origin, absence of a discrete left ventricular aneu-
rysm, multiple ventricular tachycardia configurations, pos-
terior wall site of ventricular tachycardia origin and limited
size of endocardial patch resection, to be predictors of
postsurgical arrhythmia induction or clinical recurrence .
Predictors of postoperative arrhythmia inducibility or clin-
ical recurrence . In the present series, among the eight
patients with inducible ventricular tachycardia at the
postoperative electrophysiologic study, five patients had
incomplete mapping, one patient had an inferoposterior
aneurysm and another had inferoposterior aneurysm and five
ventricular tachycardia configurations. Of the remaining
three patients who had ventricular tachycardia recurrence
(two patients) or sudden cardiac death (one patient), one had
incomplete mapping and one had an inferoposterior aneu-
rysm. Thus, 6 (67%) of the   surviving patients with incom-
plete mapping had inducible ventricular tachycardia postop-
eratively or ventricular tachycardia recurrence at follow-up,
whereas only 4 (22%) of the 18 patients with complete
mapping had inducible or spontaneous ventricular tachycar-
dia after surgery (p = 0 .03 ) . According to a recent report ( )
of surgical results in 100 patients who underwent suben-
docardial resection, the greater the percent of complete
ventricular tachycardia mapping, the better the results of
surgery, with only a 56% surgical success rate when no
mapping could be obtained, 6 % cure rate when >50% of
ventricular tachycardias could be mapped and 88% success
when all ventricular tachycardia configurations were
mapped .
Our observations that complete mapping could be per-
formed intraoperatively in only 1  (63%) of 30 patients are
consistent with previous reports (48) noting that technically
adequate intraoperative mapping could be obtained in only
53% of patients undergoing subendocardial resection for
ventricular tachycardia . The inability to induce and ade-
quately map a tachycardia intraoperatively precludes iden-
tification of the earliest site of subendocardial activation,
mandating reliance on preoperative endocardial catheter
mapping (23) or a nondirected surgical procedure (11,41,45-
47,4 ,50). Our finding that technically incomplete intraoper-
ative mapping indicates a greater chance of postoperative
ventricular tachycardia inducibility serves to emphasize the
need for preoperative catheter mapping . In patients in whom
intraoperative induction of sustained ventricular tachycardia
is not possible for various incompletely understood reasons
(41 .4 ), the data from preoperative mapping can be used (as
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in two patients in this series) to guide subendocardial resec-
tion (23) . In the present series, preoperative mapping of
ventricular tachycardia was carried out successfully in 12 of
15 patients in whom it was attempted ; mapping was per-
formed during sinus rhythm in the other 3 patients . In 2 of
the 12 patients, the findings from preoperative mapping
alone were used to guide subendocardial resection because
intraoperative mapping was incomplete. When mapping dur-
ing ventricular tachycardia (activation mapping) is impossi-
ble or incomplete, mapping during sinus rhythm or pace-
mapping has been proposed (12) . During sinus rhythm
mapping, delayed potentials are sought to identify sites of
ventricular tachycardia origin, but areas not responsible for
ventricular tachycardia may give rise to false positive results
(54). Pace-mapping has been proposed as an alternate or
supplemental technique for localizing the site of tachycardia
origin . Encouraging results of pace-mapping were recently
reported (35,36), with identification of a slow conduction
zone in the reentrant circuit of ventricular tachycardia in
humans .
In the present series, surgery was unsuccessful in all five
patients with prior cardiac arrest (four of the five had
inducible ventricular tachycardia postoperatively, including
one who also developed clinical recurrence of nonfatal
ventricular tachycardia; the fifth, with no inducible arrhyth-
mia, died suddenly) . Adverse prognostic factors were
present in four of these patients   recent myocardial infarc-
tion in one, incomplete mapping in one, both recent infarc-
tion and incomplete mapping in one and posteroinferior
aneurysm in one . However, because of the small sample size,
multivariate analysis could not determine whether this clinical
variable (prior cardiac arrest) was an independent predictor of
surgical failure . This finding is in contrast with previous
reports (8), but the reasons behind it remain elusive .
Patients who develop ventricular tachycardia or fibrilla-
tion early (within 2 months) after the first 2 days of an acute
myocardial infarction usually have a poor prognosis despite
pharmacotherapy or surgery (55,56) . Eight patients in our
series were in this category . The incidence of postoperative
ventricular tachycardia induction was higher in these pa-
tients (71% [5 of 7]) than in the patients who had a remote
(>2 months) myocardial infarction (15% [3 of 20]) (p =
0.011). The mortality rate, however, was similar in both
groups (12 .5% versus  %) . Recent studies (55,56,5 ) re-
ported encouraging results with surgery for ventricular
tachycardia in these patients, whereas earlier studies (57,58)
recommended avoiding antiarrhythmic surgery in the first 8
weeks after infarction . We do not know why the eight
patients in our series undergoing surgery within 2 months of
myocardial infarction had a high rate of ventricular tachy-
cardia induction. Although four of these eight patients had
incomplete intraoperative mapping, the history of myocar-
dial infarction remained an independent predictor of postop-
erative inducibility .
JACC Vol . 14, No . I
July 1 8  1  -208
Clinical implications . This study confirms an acceptable
operative mortality rate and long-term arrhythmia control in
this selected group of patients with drug-refractory ventric-
ular tachycardia or fibrillation . Additionally, it extends pre-
vious observations by identifying incomplete intraoperative
mapping, prior cardiac arrest and recent myocardial infarc-
tion as predictors of poor arrhythmia control after surgery .
In patients who have preoperative predictors of a poor
outcome, consideration should be given to alternative ther-
apy, such as the automatic implantable cardioverter-
defibrillator or an antitachycardia pacemaker, or both, cath-
eter ablation of ventricular tachycardia or amiodarone . In
patients whose tachycardia cannot be adequately mapped
intraoperatively, an altered surgical approach, such as an
extended endocardial resection or encircling endocardial
cryoablation, may have advantages over a localized suben-
docardial resection. Furthermore, given the higher rate of
arrhythmia inducibility and recurrence in these patients in
whom mapping cannot be performed intraoperatively, the
strategy of placing prophylactic patches for the automatic
implantable cardioverter-defibrillator should be considered
(62) .
We thank Timothy Heeren, PhD and Alexa Beiser, PhD for expert assistance
with the statistical analysis .
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